| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.082 | 0.8 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |